Skip to content

Effect of ropivacaine combined with dexamethasone nebulized inhalation on postoperative sore throat in patients with double-lumen bronchial intubation

Effect of ropivacaine combined with dexamethasone nebulized inhalation on postoperative sore throat in patients with double-lumen bronchial intubation

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079599
Enrollment
Unknown
Registered
2024-01-08
Start date
2024-01-08
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

double-lumen bronchial intubation

Interventions

Group C:Nebulized inhalation of saline 6 ml before induction of anesthesia
Group R:Nebulized inhalation of 0.5% ropivacaine 6 ml before induction of anesthesia
Group DR:Nebulized inhalation of 0.5% ropivacaine 6 ml plus 10 mg dexamethasone before induction of anesthesia

Sponsors

The First Affiliated Hospital of Gannan Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. ASA class I to III; 2. age 18 to 65 years; 3. body mass index 18 to 27.9 kg/m2; 4. thoracic surgery under elective general anesthesia with double-lumen bronchial intubation.

Exclusion criteria

Exclusion criteria: 1. anticipated difficulty in intubation; 2. recent history of cold, sore throat, hoarseness or pharyngolaryngitis; 3. indwelling gastric tube; 4. history of severe cardiovascular and cerebral vascular diseases; 5. severe abnormalities of liver and renal function; 6. allergy to the drugs used in the study; 7. severe diabetes mellitus, infections, and other diseases inappropriate for the use of hormones; 8. verbal communication barriers or other reasons for not being able to cooperate; 9. refusal to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Incidence, pain visual analog score and severity rating of sore throat at rest;Incidence, pain visual analog score and severity rating of sore throat at swallowing;

Secondary

MeasureTime frame
Incidence and severity rating of hoarseness;MAP;HR;Degree of extubation choking ;Degree of agitation during awakening;Postoperative incidence of nausea and vomiting, choking on drinking water, and reflux aspiration;

Countries

China

Contacts

Public ContactJunming Ye

The First Affiliated Hospital of Gannan Medical University

yjm9921@163.com+86 137 0797 9175

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026